Application no. and date | 13720708.0 (espacenet) (Federated) (European Patent Register), 20130424 | Patent/reg. no. and date | DK/EP 2841445, 20170614 | Publication date | 20150304 | Priority no. and date | US 201261687669 P, 20120427, US 201361775288 P, 20130308, US 201361780444 P, 20130313 | EP pub. no. and date |
EP 2841445 20150304 | Effective date | | Applicant/owner | Reata Pharmaceuticals Holdings, LLC, 5320 Legacy Drive
Plano, TX 75024, US | Applicant ref. no. | V522DKEP | Inventor | ANDERSON, Eric, 602 Nicholas Ct.
Southlake, TX 76092, US, LIU, Xiaofeng, 320 Meadowood Ln.
Coppell, TX 75019, US, DECKER, Andrea, Spalenring 11
4055 Basel, CH | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | Opponent | | IPC Class | A61K 31/565 (2006.01) , A61P 29/00 (2006.01) , C07J 63/00 (2006.01) | Title | 2,2-DIFLUORPROPIONAMIDDERIVATER AF BARDOXOLONMETHYL, POLYMORFE FORMER DERAF OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | US2013038064 | Int. publication no. | WO2013163344 | Related patent (certificate) | CA 2024 00015 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|